Furthermore, COVID-19 patients with severe respiratory failure show MAS or immune dysregulation, characterised by hyperactivated monocytes, CD4+ lymphopenia, B lymphopenia, and natural killer (NK) cytopenia [3]. This evidence concerns the gene CD4 and lymphopenia.